mortality/aging
• all mice die shortly after birth
|
renal/urinary system
• by E12.5 and E13.5, the metanephric mesenchyme exhibits increased apoptosis compared to in wild-type mice
|
• reduced in number in the kidneys that do develop
|
• 3% of mice exhibit dysgenic or hypoplastic kidneys
|
• reduced nephron number in the kidneys that do develop
|
• in 70% of mice
|
• in 27% of mice
|
• in 8% of mice lacking one or both kidneys
|
• at E12.5 and E13.5, ureteric bud branching is impaired unlike in wild-type mice
• ureteric buds fail to branch in vitro in response to GDNF-containing matrigel unlike similarly treated wild-type cells
|
• at E11.5, no ureteric bud is detected in the metanephric mesenchyme unlike in wild-type mice
• urogenital blocks grown in vitro and stimulated with GDNF fail to form ectopic ureteric buds unlike similarly treated wild-type tissue
• ureteric buds prevent wild-type metanephric mesenchyme from undergoing nephrogenesis when combined
|
behavior/neurological
• at birth, mice exhibit a bent body posture unlike wild-type mice
|
growth/size/body
embryo
• by E12.5 and E13.5, the metanephric mesenchyme exhibits increased apoptosis compared to in wild-type mice
|
• mesonephros contain fewer mesonephric tubules compared to in wild-type tissue
• mesonephros stimulated with lithium fail to form brush-boarder-positive proximal tubules unlike similarly treated wild-type tissue
|
cardiovascular system
N |
• mice do not exhibit heart defects
|
integument
N |
• mice do not exhibit skin defects
|
cellular
• by E12.5 and E13.5, the metanephric mesenchyme exhibits increased apoptosis compared to in wild-type mice
|